Leopoldo Rivera-Castaño, H. Sentíes-Madrid, Jesús Berumen-Jaik, I. Martínez-Juárez
{"title":"Guía clínica. Fármacos antiepilépticos de elección para crisis focales y generalizadas en adultos","authors":"Leopoldo Rivera-Castaño, H. Sentíes-Madrid, Jesús Berumen-Jaik, I. Martínez-Juárez","doi":"10.24875/rmn.m19000055","DOIUrl":null,"url":null,"abstract":"The mainstay of treatment in patients with epilepsy is the use of antiepileptic drugs (AEDs). Currently, there are a significant number of AEDs in Mexico. For the pharmacological management of the patient with epilepsy, it is important to know the pharmacokinetics, dosage, mechanism of action, and formulations of the AEDs. 70-80% of patients with either focal or generalized seizures are completely seizure free on AED monotherapy. When, despite the use of AED in monotherapy, seizure freedom is not achieved, a second AED should be used; AEDs with different mechanisms of action are empirically combined el 100% de control; sin embargo, es importante considerar que de un 20 a un 30% no logra esta meta 3 .","PeriodicalId":53921,"journal":{"name":"Revista Mexicana de Neurociencia","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Mexicana de Neurociencia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/rmn.m19000055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The mainstay of treatment in patients with epilepsy is the use of antiepileptic drugs (AEDs). Currently, there are a significant number of AEDs in Mexico. For the pharmacological management of the patient with epilepsy, it is important to know the pharmacokinetics, dosage, mechanism of action, and formulations of the AEDs. 70-80% of patients with either focal or generalized seizures are completely seizure free on AED monotherapy. When, despite the use of AED in monotherapy, seizure freedom is not achieved, a second AED should be used; AEDs with different mechanisms of action are empirically combined el 100% de control; sin embargo, es importante considerar que de un 20 a un 30% no logra esta meta 3 .